Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase of the Class XVI that has been found to be implicated in multiple cancers through aberrant activation due to point mutations, overexpression, or a diversity of translocations giving rise to fusion proteins [99]. This evidence concerns the gene ALK and cancer.